Home/Motif Neurotech/Jacob Robinson, PhD
JR

Jacob Robinson, PhD

Co-founder, CEO

Motif Neurotech

Therapeutic Areas

Motif Neurotech Pipeline

DrugIndicationPhase
DOTTreatment-Resistant Depression (TRD)Pre-clinical